<DOC>
	<DOC>NCT02215941</DOC>
	<brief_summary>The primary objective of this study is to characterize the pharmacokinetics of TV-45070 in plasma following single and multiple-dose topical application of 8% TV-45070 ointment.</brief_summary>
	<brief_title>Study to Characterize the Pharmacokinetics and Safety of TV-45070 Ointment in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male and/or female subjects aged 18 to 50 years Body Mass Index (BMI) ≥18.0 and ≤32.0 kg/m2. Able and willing to provide written informed consent. Able and willing to comply with all study procedures and restrictions. History or evidence of clinically significant illness or surgery Presence of open wounds, sunburn, tattoo, major scarring, nonintact or damaged in the proposed application area that would interfere with the application of the study drug treatments or biopsies. History of significant drug or alcohol abuse Use of prescription drugs within 30 days or 5 halflives (whichever is longer) prior to Day 1. Use of topical application of an OTC medicated or prescription medication or other skin creams/ointments (eg, moisturizers, balms) in the areas intended for study drug administration within 7 days prior to Day 1. Use of topical capsaicin within 6 months prior to Day 1. Pregnant or nursing females Shaving or waxing the planned study treatment application area within 7 days prior Day 1. Laser hair removal of the planned study treatment application area within 2 months prior to Day 1. other criteria apply, please contact the investigator for more information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>